Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
Park HS, Kim HS, Beom SH, Rha SY, Chung HC, Kim JH, Chun YJ, Lee SW, Choe EA, Heo SJ, Noh SH, Hyung WJ, Cheong JH, Kim HI, Son T, Lim JS, Baek SE, Jung M. Park HS, et al. Among authors: kim hi, kim hs, kim jh. Ann Surg Oncol. 2018 Oct;25(11):3222-3230. doi: 10.1245/s10434-018-6624-1. Epub 2018 Jul 26. Ann Surg Oncol. 2018. PMID: 30051367 Clinical Trial.
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma.
Kim CG, Sim NS, Kim JE, Yun KH, Lee YH, Kim SH, Baek W, Han YD, Kim SK, Kim JH, Koh YW, Jung I, Shin SJ, Rha SY, Ahn JH, Kim HS. Kim CG, et al. Among authors: kim sh, kim sk, kim je, kim hs, kim jh. Clin Cancer Res. 2022 Aug 2;28(15):3225-3234. doi: 10.1158/1078-0432.CCR-22-0518. Clin Cancer Res. 2022. PMID: 35583824 Clinical Trial.
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response.
Kim CG, Koh JY, Shin SJ, Shin JH, Hong M, Chung HC, Rha SY, Kim HS, Lee CK, Lee JH, Han Y, Kim H, Che X, Yun UJ, Kim H, Kim JH, Lee SY, Park SK, Park S, Kim H, Ahn JY, Jeung HC, Lee JS, Nam YD, Jung M. Kim CG, et al. Among authors: kim h, kim hs, kim jh. Cell Rep Med. 2023 Nov 21;4(11):101251. doi: 10.1016/j.xcrm.2023.101251. Epub 2023 Oct 26. Cell Rep Med. 2023. PMID: 37890486 Free PMC article.
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG, Ahn JB, Jung M, Beom SH, Heo SJ, Kim JH, Kim YJ, Kim NK, Min BS, Koom WS, Kim H, Roh YH, Ma BG, Shin SJ. Kim CG, et al. Among authors: kim yj, kim h, kim nk, kim jh. Ann Surg Oncol. 2017 Jan;24(1):227-235. doi: 10.1245/s10434-016-5613-5. Epub 2016 Oct 3. Ann Surg Oncol. 2017. PMID: 27699609
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
Kim JH, Shin SJ, Heo SJ, Choe EA, Kim CG, Jung M, Keum KC, Yoon JS, Lee SC, Shin SJ. Kim JH, et al. Among authors: kim cg. Cancer Res Treat. 2018 Oct;50(4):1238-1251. doi: 10.4143/crt.2017.534. Epub 2017 Dec 28. Cancer Res Treat. 2018. PMID: 29281872 Free PMC article.
32,334 results
You have reached the last available page of results. Please see the User Guide for more information.